🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with new zealand medsafe? Page 5

Has anyone dealt with new zealand medsafe?

newstart_MO Sun, Nov 23, 2025 at 11:31 PM 27 replies 1,132 viewsPage 5 of 6
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Nov 24, 2025 at 6:36 AM#21

dan_philly — that is really helpful context on Has anyone dealt with new. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

Last edited: Nov 24, 2025 at 7:36 AM
47 13amy_econ_NJ, bbq_ray_KC, oliver_london and 44 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Nov 24, 2025 at 6:53 AM#22

To answer SarahChen_PharmD's question specifically:

From a clinical standpoint, Has anyone dealt with new is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

34 11maya_sedona, stefan_berlin, Dr.EM_Chicago and 31 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Nov 24, 2025 at 7:10 AM#23

Thank you SallyK_inj! This is incredibly helpful. Taking this to my next appointment. 🙏

48 5JessicaM_2024, TomFromTexas, mike.trainer_LA and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Nov 24, 2025 at 7:27 AM#24

Relevant to Has anyone dealt with new — here is my latest bloodwork comparison:

Key improvements: A1C 7.2% → 5.3%, triglycerides 191 → 91 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Nov 24, 2025 at 12:27 PM
19 19Dr.PulmRoch, maya_sedona, stefan_berlin and 16 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Nov 24, 2025 at 7:44 AM#25

Slightly tangential to Has anyone dealt with new but SallyK_inj reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Nov 24, 2025 at 10:44 AM
39 0TrialTracker_MD, JennaRN, LabKate and 36 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register